Ongoing
HORIZONT 2020 Project ERA Chair Of Micro Process Engineering and TEchnology – COMPETE
One of main focuses of ERA Chair COMPETE is to implement and develop microfluidics methodology for biotechnological and biomedical applications
ERA Chair Holder: dr. Tadej Kokalj, Project coordinator: Prof. Polona Žnidaršič Plazl, Period: 2019 – 2023, Funding: European Commission
J3-3077 Multilayer network analysis of collective cellular activity in normal and diabetic pancreatic islets
PI: dr. Marko Gosak, 1.10.2021 – 30.9.2024, ARRS
COST action CA16122: Biomaterials and advanced physical techniques for regenerative cardiology and neurology
Chair: Prof. Franco RUSTICHELLI (IT)
Participating countries: Algeria, Argentina, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Denmark, Finland, France, FYR Macedonia, Germany, Greece, Great Britain, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United States of America
Period: 15.3.2017-14.3.2022, Funding: European Commission
Closed
COST action CA16113 CliniMARK : ‘good biomarker practice’ to increase the number of clinically validated biomarkers
Chair: Dr. Theo M. LUIDER
M. Pavlin MC for Slovenia.
Period: 14.3.2017-13.3.2021, Funding: European Comission
J7-7424: Evaluation of possible harmful effects of nanoparticles and underlying mechanisms: from physico-chemical and in vitro toxicity characterisation to innate immune system activation
PI: dr. Vladimir B. Bregar
Period: 1.1.2016―31.12.2018, Funding: ARRS
Project description /// Opis projekta
Z4-8229: The effects of different types of nanoparticles on neural cells and macrophages – analysis of short-term and long-term effects on cell stress, differentiation and cell signalling
PI: dr. Jasna Lojk
Period: 1.5.2017―30.4.2019, Funding: ARRS
Project description /// Opis projekta
J3-6794: Cellular energy metabolism as a target for cancer therapy – genetic and pharmacological approach
PI: dr. Mojca Pavlin
Period: 1.7.2014―30.6.2017, Funding: ARRS
Project description /// Opis projekta
J2-6758: Development and in vitro characterization of multimodal magnetic nanoparticles for drug delivery and cell tracking
PI: dr. Vladimir B. Bregar
Period: 1.7.2014―30.6.2017, Funding: ARRS
Project description /// Opis projekta
J4-4324: Gene electrotransfer of muscle – from studies on single cells to numerical optimization of parameters in tissue
PI: dr. Mojca Pavlin
Period: 1.7.2011―30.6.2014, Funding: ARRS
J2-2249: Analisis of functionalization and mobility of magnetic nanoparticles in vitro for biomedical aplications
PI: dr. Vladimir B. Bregar
Period: 1.1.2009―30.4.2012, Funding: ARRS
J2-9770:Mechanisms of DNA delivery with electrogene transfer
PI: dr. Mojca Pavlin
Period: 1.1.2007―31.12.2010, Funding: ARRS